Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nasopharyngeal Cancer Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nasopharyngeal Cancer Drugmarket, defines the market attractiveness level of Nasopharyngeal Cancer Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nasopharyngeal Cancer Drug industry, describes the types of Nasopharyngeal Cancer Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nasopharyngeal Cancer Drug market and the development prospects and opportunities of Nasopharyngeal Cancer Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nasopharyngeal Cancer Drug market in Chapter 13.
By Player:
CBT Pharmaceuticals Inc
Bristol-Myers Squibb Company
Celgene Corp
Cell Medica Ltd
Biomics Biotechnologies Co Ltd
BioDiem Ltd
AVEO Pharmaceuticals Inc
arGEN-X BV
GlaxoSmithKline Plc
BeiGene Ltd
Atara Biotherapeutics Inc
F Hoffmann-La Roche Ltd
Ambrx Inc
By Type:
BGBA-317
CBT-501
Apatinib
APG-1387
ARGX-110
ATA-129
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nasopharyngeal Cancer Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nasopharyngeal Cancer Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nasopharyngeal Cancer Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nasopharyngeal Cancer Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nasopharyngeal Cancer Drug Market Analysis and Outlook to 2022
-
7.1 Global Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.2 United States Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.3 Europe Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.4 China Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.5 Japan Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.6 India Nasopharyngeal Cancer Drug Consumption (2017-2022)
-
7.7 South Korea Nasopharyngeal Cancer Drug Consumption (2017-2022)
8 Region and Country-wise Nasopharyngeal Cancer Drug Market Analysis and Outlook to 2028
-
8.1 Global Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.2 United States Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.3 Europe Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.4 China Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.5 Japan Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.6 India Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Nasopharyngeal Cancer Drug Consumption Forecast (2022-2028)
9 Global Nasopharyngeal Cancer Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Nasopharyngeal Cancer Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global BGBA-317 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global CBT-501 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Apatinib Consumption and Growth Rate (2017-2022)
-
9.1.4 Global APG-1387 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global ARGX-110 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global ATA-129 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Nasopharyngeal Cancer Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Nasopharyngeal Cancer Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global BGBA-317 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global CBT-501 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Apatinib Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global APG-1387 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global ARGX-110 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global ATA-129 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Nasopharyngeal Cancer Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nasopharyngeal Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nasopharyngeal Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nasopharyngeal Cancer Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nasopharyngeal Cancer Drug Market Competitive Analysis
-
14.1 CBT Pharmaceuticals Inc
-
14.1.1 CBT Pharmaceuticals Inc Company Details
-
14.1.2 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product and Service
-
14.2 Bristol-Myers Squibb Company
-
14.2.1 Bristol-Myers Squibb Company Company Details
-
14.2.2 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Product and Service
-
14.3 Celgene Corp
-
14.3.1 Celgene Corp Company Details
-
14.3.2 Celgene Corp Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Celgene Corp Nasopharyngeal Cancer Drug Product and Service
-
14.4 Cell Medica Ltd
-
14.4.1 Cell Medica Ltd Company Details
-
14.4.2 Cell Medica Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Cell Medica Ltd Nasopharyngeal Cancer Drug Product and Service
-
14.5 Biomics Biotechnologies Co Ltd
-
14.5.1 Biomics Biotechnologies Co Ltd Company Details
-
14.5.2 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Product and Service
-
14.6 BioDiem Ltd
-
14.6.1 BioDiem Ltd Company Details
-
14.6.2 BioDiem Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 BioDiem Ltd Nasopharyngeal Cancer Drug Product and Service
-
14.7 AVEO Pharmaceuticals Inc
-
14.7.1 AVEO Pharmaceuticals Inc Company Details
-
14.7.2 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product and Service
-
14.8 arGEN-X BV
-
14.8.1 arGEN-X BV Company Details
-
14.8.2 arGEN-X BV Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 arGEN-X BV Nasopharyngeal Cancer Drug Product and Service
-
14.9 GlaxoSmithKline Plc
-
14.9.1 GlaxoSmithKline Plc Company Details
-
14.9.2 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Product and Service
-
14.10 BeiGene Ltd
-
14.10.1 BeiGene Ltd Company Details
-
14.10.2 BeiGene Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BeiGene Ltd Nasopharyngeal Cancer Drug Product and Service
-
14.11 Atara Biotherapeutics Inc
-
14.11.1 Atara Biotherapeutics Inc Company Details
-
14.11.2 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Product and Service
-
14.12 F Hoffmann-La Roche Ltd
-
14.12.1 F Hoffmann-La Roche Ltd Company Details
-
14.12.2 F Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 F Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Product and Service
-
14.13 Ambrx Inc
-
14.13.1 Ambrx Inc Company Details
-
14.13.2 Ambrx Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Ambrx Inc Nasopharyngeal Cancer Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nasopharyngeal Cancer Drug
-
Figure Nasopharyngeal Cancer Drug Picture
-
Table Global Nasopharyngeal Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasopharyngeal Cancer Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasopharyngeal Cancer Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nasopharyngeal Cancer Drug Consumption by Country (2017-2022)
-
Figure United States Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure China Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure India Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nasopharyngeal Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Nasopharyngeal Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nasopharyngeal Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global BGBA-317 Consumption and Growth Rate (2017-2022)
-
Figure Global CBT-501 Consumption and Growth Rate (2017-2022)
-
Figure Global Apatinib Consumption and Growth Rate (2017-2022)
-
Figure Global APG-1387 Consumption and Growth Rate (2017-2022)
-
Figure Global ARGX-110 Consumption and Growth Rate (2017-2022)
-
Figure Global ATA-129 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global BGBA-317 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CBT-501 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Apatinib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global APG-1387 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ARGX-110 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ATA-129 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nasopharyngeal Cancer Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nasopharyngeal Cancer Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table CBT Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CBT Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Nasopharyngeal Cancer Drug Product and Service
-
Table Celgene Corp (Foundation Year, Company Profile and etc.)
-
Table Celgene Corp Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corp Nasopharyngeal Cancer Drug Product and Service
-
Table Cell Medica Ltd (Foundation Year, Company Profile and etc.)
-
Table Cell Medica Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Medica Ltd Nasopharyngeal Cancer Drug Product and Service
-
Table Biomics Biotechnologies Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biomics Biotechnologies Co Ltd Nasopharyngeal Cancer Drug Product and Service
-
Table BioDiem Ltd (Foundation Year, Company Profile and etc.)
-
Table BioDiem Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioDiem Ltd Nasopharyngeal Cancer Drug Product and Service
-
Table AVEO Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AVEO Pharmaceuticals Inc Nasopharyngeal Cancer Drug Product and Service
-
Table arGEN-X BV (Foundation Year, Company Profile and etc.)
-
Table arGEN-X BV Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table arGEN-X BV Nasopharyngeal Cancer Drug Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Nasopharyngeal Cancer Drug Product and Service
-
Table BeiGene Ltd (Foundation Year, Company Profile and etc.)
-
Table BeiGene Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table BeiGene Ltd Nasopharyngeal Cancer Drug Product and Service
-
Table Atara Biotherapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atara Biotherapeutics Inc Nasopharyngeal Cancer Drug Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Nasopharyngeal Cancer Drug Product and Service
-
Table Ambrx Inc (Foundation Year, Company Profile and etc.)
-
Table Ambrx Inc Nasopharyngeal Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ambrx Inc Nasopharyngeal Cancer Drug Product and Service
-
